Canna360

Cannabis 360
Second Annual Industry Conference

Cannabis 360 features industry leaders and experts covering important issues and current challenges related to cannabis and psychedelics. Cannabis 360 aims to provide key insights on the biggest opportunities within these emerging markets, both in Canada and abroad. Our speakers will provide actionable takeaways for attendees, whether you are new to the industry, or an established business searching for growth opportunities.

We encourage industry professionals—from cultivators, manufacturers, retail operators, consultants, lawyers, investors, regulators, medical professionals, scientists, and researchers —join us at the Cannabis 360 Conference to receive expert training and insights across a variety of sectors and disciplines.

DATE:

SEPTEMBER 29th 2022

TIME:

9AM - 5PM EST

GENERAL ADMISSION FEE:

CAD $50

REGISTER NOW

EVENT FEATURES

  • In-depth discussions covering key aspects of the cannabis industry
  • Networking opportunity with industry professionals and experts
  • Technical knowledge from industry leaders and regulatory specialists
  • A virtual conference that can be accessed anywhere in the world

EXPERT SPEAKERS

Our expert panelists consist of regulatory specialists, scientists, and business leaders
providing diverse perspectives on the cannabis and psychedelic industry. Our aim is to deliver valuable educational content and networking opportunities for all attendees.
Laleh Bighash

AAPS

President and Dean of Scientific Affairs

Deepak Anand

Materia

Chief Executive Officer

Lucas C. McCann

CannDelta

Co-founder & Chief Scientific Officer

Atiyyah Ferouz

Agcann

Founder/CEO

Colin Bambury

Ghost Drops

Marketing Manager

Alexzander Samuelsson

HAVN Life

Co-Founder and Chief Research Officer

Dr. Paola Cubillos

Knowde Group

Medical and Scientific Advisor

Shahbaaz Kara-Virani

Kind

Managing Director

Codi Peterson

The Cannigma

Chief Science Officer

Jenna Perry

Spiffy

Manager of Customer Success

Patrick Moher

Microdose HQ

President

Peter Cogan

Regis University

Associate Professor of Pharmaceutical Sciences

Elliot Galbraith

Canna Cabana

Category Buyer

Tabitha Fritz

Fritz’s Cannabis Company

Co-founder/CEO

Matthew Jerome

Meristem Cannabis Consulting

Founder and Chief Consultant

Adam Greenblatt

Consultant/Educator

Brian Pilecki


Clinical Psychologist

Jeff Goldenberg

Abacus Agency

Co-founder

Hardeep Shoker

Elevated Signals

Chief Product Officer

Sabrina Ramkellawan



Chris Budd

Isolocity

Director of Sales

Natalie Villeneuve



Christopher Tasker

Global Cannabinoid Solutions

Founder & CEO

Tamara Lilien

CannSell

Head of Education

Carl K Linn

Founder, Thai Hub of Cannabis

Author, Cannabis in Thailand

Samantha Tabone


Chemist and Pharmaceutical Scientist

Mark Johnson

Centricity Research

Chief Executive Officer and Medical Director

More Speakers To Be Announced

15+ Experts

SCHEDULE

SEPTEMBER 29, 2022

  • 9:00 - 9:15 AM

Welcome Remarks

  • 9:15 - 10:00 AM

International Cannabis Markets and Business Opportunities: UK, Europe, and Asia

The international cannabis market is heating up, with new developments in countries such as Germany, Thailand, Spain, Switzerland, and the UK happening on a regular basis. As the cannabis industry matures, understanding where the biggest opportunities exist is critical. In this panel, hear from industry leaders on the recent developments happening in the key markets around the world, the different licensing processes, frameworks, and overall potential in these new markets.
  • 10:00 - 10:45 AM

Psychedelics: Market Potential and Opportunities

While psychedelics continue to gain momentum as a legitimate medical treatment, access to psychedelic therapies remains restricted in most parts of the world. Despite the difficulties in accessing psychedelic medicine, opportunities still exist from a business perspective for prospective companies looking to join this exciting new space. In this panel, learn about the different regulatory framework and licensing processes needed to start a psychedelic business, in Canada and abroad.
  • 10:45 - 11:30 AM

Empowering Your Budtenders: Education, Training and Career Advancement

Budtenders are often regarded as the driving force behind getting cannabis brands into the hands of consumers. Although the importance of budtenders is well-recognized by the industry, high turnover rates, lack of education and poor training has hampered the potential for many industry hopefuls to pursue budtending as a potential career path. Learn from industry experts on how to best support your budtenders through education and training and retain your top talent.
  • 11:30 - 12:15 PM

Psychedelic Therapy: Harm-Reduction, Risks and Ethical Concerns

As interest in the promise of psychedelic therapies continues to increase across the globe, there are concerning reports of abuse and ethical misconduct happening within psychedelic practices. As a result, there is a clear need to integrate a harm reduction approach and develop a stringent code of ethics and training programs for therapists while also acknowledging the voices of survivors raising these concerns. Panelist will cover these issues in detail and discuss how psychedelic therapy can be improved moving forward to establish safe and effective ways these substances can be integrated within a therapeutic context.
  • 12:15 - 1:00 PM

Lunch Break

  • 1:00 - 1:45 PM

Terpenes and the Entourage Effect: Separating the Science from Marketing Buzz

The entourage effect has become widely adopted by the cannabis industry with proponents insisting that cannabinoids work along with terpenes to create certain effects associated with cannabis consumption. However, scientific evidence for the entourage effect is limited and further research is still required. In this panel, our panelist will provide a comprehensive breakdown this often-misunderstood phenomenon.
  • 1:45 - 2:30 PM

Creating Operational Efficiency Through Technology

Compliance has remained an integral part of the cannabis industry with technology evolving rapidly over the last few years to help companies reduce costs, human error, and inefficient processes within the facility. Panelist will discuss how technology can be utilized to save you time and money, move beyond traditional record keeping practice, reduce organizational risk and ensure that you always remain compliant while also improving workflow and process efficiency.
  • 2:30 - 3:15 PM

How to Create a Cannabis Brand That Resonates with Consumers

Cannabis companies have had a difficult time standing out from the myriad of brands currently available on the market. However, some brands have managed to make a significant impact, winning the hearts and minds of cannabis consumers, and establishing a strong foothold in the industry. Panelists will discuss tools and approaches to create a brand that resonates with consumers and explore innovative marketing techniques.
  • 3:15 - 4:00 PM

The Future of Clinical Trials with Psychedelics

In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety, and posttraumatic stress disorder (PTSD). The panel of experts will briefly discuss the different phases of clinical trials, the research design process, challenges related to site selection and how they envision clinical trials with psychedelics progressing over the next several years.
  • 4:00 - 4:15 PM

Closing Remarks

10+ Companies

OUR SPONSORS

We are inviting a limited number of organizations to join as Sponsors of the event.

For more information or to express an interest please reach out to info@canna360.ca

If you are interested in sponsorship opportunities with Cannabis 360, contact us today!
Sponsor Cannabis 360
Laleh Bighash

AAPS

President and Dean of Scientific Affairs

Ms. Bighash has a Bachelor of Pharmacy, and a Bachelor degree in Pharmacology and Toxicology from University of Toronto, Canada. She also obtained her Masters degree in Business Administration (MBA) from Schulich School of Business. She is a recipient of 2019 UC-University of Toronto alumni of influence award and has been nominated for the Canadian Women Entrepreneur Award. In her current role as the President of AAPS, a post-graduate private college focusing on pharmaceutical and food higher education, she oversees the strategic, educational and training direction of AAPS. She has over 27 years of experience working for a number of multinational pharmaceutical companies such as Genpharm Inc., Bayer Corp. and Eli Lilly & Company. Laleh has also worked with a number of Food and Cannabis organizations in various capacities such as Research and Development, Quality Control, Quality Assurance, Regulatory and Compliance, Strategic Planning, and Business development.

Ms. Bighash has lectured extensively and has been an invited speaker at many global and Canadian academic and industry events focusing on pharma, food and cannabis-related topics such as regulatory, compliance and efficient operations. She has worked closely with the industry players and stakeholders in formulating efficient operating systems, ensuring regulatory compliance and certification.

Deepak Anand

Materia

Chief Executive Officer

Mr. Anand has a wealth of knowledge and experience in the global cannabis industry. He is a public speaker and is regularly engagedwithCanadianand International media on all subjects related to the Cannabis industry. Mr. Anand holds a Master’s in Business Administration (MBA) and Management From VancouverIsland University.He is a recognized thought leaders and brings 15 years of leadership experience inthe health, charitable/non-profit, and private sectors inCanada.

Within the global cannabis sector, Mr. Anand has worked with senior government officials, politicians, policy makers, health professional organizations, clinical practitioners, educators, investor, patients as well as producers. He has also served on the boards of various pharmaceutical associations across Canada, the United States and Europe.

Currently, Mr. Anand serves on a variety of boards within the international cannabis space which include not for profit, advocacy and patient driven organizations.

Lucas C. McCann

CannDelta

Co-founder & Chief Scientific Officer

Dr. Lucas C. McCann is the Co-Founder and Chief Scientific Officer at CannDelta Inc. where he provides scientific oversight on all projects. A medicinal organic chemist by training, Lucas acquired regulatory knowledge within the Regulatory and Operations Enforcement Branch for Health Products within Health Canada before moving into the private consulting space.

Leveraging his science background he has catapulted himself to the frontlines, where technology, cannabis, and regulation interface. He specializes in chemical synthesis, laboratory processes and building science-forward cannabis companies. Lucas guides his clients through Health Canada’s Cannabis Regulations and the licensing process by working to create compliant business and scientific strategies for start-ups to publicly traded licensed producers.

Lucas holds a Ph.D. in combinatorial chemistry from York University (Toronto), a Masters’ degree in Natural Product Synthetic Chemistry from Laval University (Quebec City) and a B.Sc. from the Faculty of Applied Sciences at Simon Fraser University (Burnaby).

Atiyyah Ferouz

Agcann

Consulting

Atiyyah Ferouz is a cannabis industry professional and entrepreneur, founding AgCann Consultancy Ltd. in November 2020. AgCann Consultancy is to help cannabis producers bridge the gap between where they are, and where they want to be. Atiyyah Ferouz utilize her experience in operations, quality assurance, regulatory, sales, and business development to provide tailored solutions for each organization. Where applicable, she incorporate her expertise in plant science, ensuring that all processes are geared towards optimized plant health and performance.

Atiyyah Ferouz is also an instructor at the Academy of Applied Pharmaceutical Sciences where I teach edibles processing, product development, and food safety courses.

Colin Bambury

Ghost Drops

Marketing Manager

Colin Bambury is a creative marketer and entrepreneur focused on the cannabis industry. Colin got his start in the early legacy market and has worked in legal cannabis since 2016. Bambury founded ADCANN, the number one educational resource for industry marketers in 2018 and grnhouse, an agency that represents a variety of cannabis-related clients in 2021. Having worked with top companies in the space including Weedmaps, 7ACRES, Khalifa Kush, THC Canada and more – Colin is currently the Marketing Manager at leading premium Canadian cannabis brand, Ghost Drops.
Dr. Paola Cubillos

Knowde Group

Medical and Scientific Advisor

Paola is a Colombian-Canadian physician, specialist in integrative medicine, a recognized international speaker on topics related to the evidence-based use of medical cannabis and the ethics of medical cannabis research. She is currently the medical and scientific advisor for the Canadian cannabinoid and psychedelic contract research organization Knowde Group Inc., she is vice president of the Interdisciplinary Latin American Society of Cannabinology, the coordinator of the diploma course in therapeutic applications of cannabinoids at the Universidad del Rosario de Bogotá, Colombia, and is part of the teaching staff and the academic coordination of the International Diploma in Endocannabinology of the PUIS of the UNAM. Paola has directed the Oncology Research board of the Princess Margaret Hospital in Toronto, and has chaired research ethics committees in her home country, Colombia.
Shahbaaz Kara-Virani

Kind

Managing Director

Shahbaaz has spent the last 5 years dedicating his life and career to improving cannabis accessibility globally. He spent 18 months as the head of sales at Lift&Co, helping launch Cannsell and the Lift Expos as well as 2 years at Dutchie as the director of the Canadian team, helping bring e commerce and POS to retailers in Canada. Currently he is the Managing Director of KIND and helped drive the first and largest legal budtender sampling event. He is passionate about cannabis and sports and hopes to one day help the Canadian Beach Soccer team leverage cannabis to win a global championship.
Codi Peterson

The Cannigma

Chief Science Officer

Dr. Codi Peterson is a pediatric pharmacist and cannabis science expert. Leveraging a decade of clinical pharmacy experience, Codi strives to bridge the gap between healthcare and cannabis through education and advocacy. He is PharmD graduate from Duquesne University and later graduated with an MS in Medical Cannabis Science & Therapeutics. Codi is the Chief Science Officer of The Cannigma, a science forward media company who wants to help the world get cannabis. Dr. Peterson is also an educator for OCEMT where he teaches pharmacology to paramedics in Southern California. Codi is co-founder of the Pharmacists Cannabis Coalition of California (PCCC), a public-benefit nonprofit dedicated to educating and elevating California pharmacists in the cannabis space. Additionally Codi is an advisor to numerous companies in the cannabis industry, including Hembel and the Cannabis Spa Association. He believes that cannabis is medicine and patients deserve access to medicine, which includes the right to speak with a healthcare professional.
Jenna Perry

Spiffy

Manager of Customer Success

Jenna Perry is a seasoned customer success expert focusing on driving engagement and education within the cannabis industry. The Cannabis Industry provides a unique challenge to cultivate a great customer experience for all patrons, from newcomers to experienced users. Jenna connects with Cannabis Producers and Storefronts daily to ensure that all retail team members are equipped with the knowledge to create a remarkable in-house experience while maintaining brand standards.
Patrick Moher

Microdose HQ

President

Amplifying impact as a dynamic and socially-conscious entrepreneur, Patrick uses his creativity and passion for human connectivity/happiness to unite individuals across social and corporate spectrums.

Evolving from a successful career in photography, and co-founding a number of cannabis companies, Patrick’s focus is helping businesses achieve financial success while supporting nonprofits & charities in emerging industries.

Currently President at Microdose Psychedelic Insights, he’s developing the organization into the industry’s premier events and media platform alongside a highly motivated and engaged startup team.
Peter Cogan

Regis University

Associate Professor of Pharmaceutical Sciences

Dr. Cogan received his Ph.D. in Pharmaceutical Sciences from the University of Colorado School of Pharmacy, where his training under professor Tad Koch was focused in the field of bioorganic and medicinal chemistry. His postdoctoral studies in phosphoramidite and oligonucleotide chemistry were continued at the University of Colorado under Professor Marvin Caruthers. His past research interests have included the design and synthesis of superpotent anthracycline prodrugs, orthogonal nucleotide protecting groups, and novel ionic liquid solvent systems amenable to phosphoramidite coupling.

Dr. Cogan’s current research interest lies in the realm of medical marijuana and is focused on investigating the evidence for popular therapeutic claims made of cannabidiol and other cannabinoids.
Elliot Galbraith

Canna Cabana

Category Buyer

Working as a Category Buyer for Canna Cabana, Elliot Galbraith brings over two years of cannabis retail experience from managing one of the original twenty-five Ontario stores: Canna Cabana – Yonge Street. Elliot fell in love with cannabis while completing his undergrad at the Liberal Arts College of Concordia University in Montreal, where he could be found cultivating and consuming anywhere he could get away with it. When legalization was realized, he jumped at the idea of a career in cannabis and enrolled at AAPS, earning a Diploma in Cannabis: Management, Quality, & Edibles. Elliot was hired at Canna Cabana as the franchised stores Assistant Manager. A year later, he was promoted to Store Manager and the store was acquired by High Tide Inc. Elliot Galbraith’s passion for great cannabis experiences continues, as he looks forward to bringing Cabana Cannabis Co. white label products to market when he isn’t busy “testing” products or cultivating his own crop.
Tabitha Fritz

Fritz’s Cannabis Company

Co-founder/CEO

Tabitha Fritz is the co-founder and CEO of Fritz’s Cannabis Company, an edibles company that was established in 2016, and successfully transitioned from the legacy market to the regulated Canadian space in 2021. Fritz’s products are currently listed throughout Canada, and the company recently launched the first solvent-free edible in the regulated Canadian market. At the same time she was co-founding Fritz’s, Tabitha was co-founding Bast, a cannabis brand that formulates cannabis products for women, including a condom-compatible personal lubricant, suppositories, and infused topicals.

Prior to working in the cannabis industry, Tabitha was a teacher, curriculum developer, and educational administrator, roles that helped her develop her skills as a cannabis educator and create comprehensive budtender training curriculums, including the Level UP Budtender Education Program, the first online and in-person training program made specifically for Canadian budtenders. Through her varied experiences in connecting face-to-face with consumers during Fritz’s legacy market days and her work with budtenders and retailers, Tabitha has developed a deep understanding of cannabis products, the Canadian consumer, and the spaces where they intersect. This understanding informs her work creating and presenting workshops on a variety of cannabis education topics, including her most recent online course “The 5 Dimensions of a Cannabis Experience”.

Tabitha is a board member of The Hash Corporation, a publicly traded company that produces traditional cannabis hashish, as well as the Canadian Business History Association, an organization dedicated to the preservation and presentation of Canadian Business History. She holds an MBA from the University of Toronto, where she studied behavioural economics and entrepreneurship.
Matthew Jerome

Meristem Cannabis Consulting

Founder and Chief Consultant

Matthew Jerome is the Founder and Chief Consultant at Meristem Cannabis Consulting and is Canada’s first fully certified Ganjier. Matt has over 15 years experience in the cannabis field and began his journey in early 2007 as a medicinal patient and designated grower as well as advocate. In 2011 he branched out and began his career as an educator and medicinal/craft consultant in the legacy market until pre-legalization, during which he worked as a policy advisor and patient care coordinator within the industry.

During this time however, Matt noticed some serious gaps in the narrative and found himself thoroughly disappointed at the lack of attention being dedicated to the medical cannabis community on the road to legalization and decided to do something about it. In 2019 Matt founded Meristem Cannabis Consulting with a dedicated goal in mind to represent the medicinal community the way they deserved to be, and to make sure that those who were unable to fights for themselves were never left out of the conversation.

Matt has also been a vocal cannabis advocate for over a decade and has been featured as a key-note speaker at several cannabis events and competitions. Matt is also a professional cannabis judge and has judged a number of competitions worldwide. He offers one-of-a-kind systematic cannabis assessments to growers and breeders of all types, with a goal to educate and advise companies and individuals within the industry on the importance of quality within the supply chain, as well as provide confidence when it comes to quality related decisions.
Brian Pilecki

Clinical Psychologist

Dr. Brian Pilecki is a clinical psychologist at Portland Psychotherapy that specializes in the treatment of anxiety disorders, trauma and PTSD, and psychedelic-assisted therapy. Brian practices from an orientation based in Acceptance and Commitment Therapy (ACT) and has extensive experience in the areas of mindfulness and meditation that he incorporates into therapy with clients. At Portland Psychotherapy, Brian is an active researcher and a study therapist on a clinical trial investigating the use of MDMA-assisted therapy for the treatment of social anxiety disorder and understanding processes of change in psychedelic therapy. He is a consultant and instructor for Fluence Training and co-chairperson for the Psychedelic Special Interest Group of the Association for Contextual Behavioral Science. He also co-hosts a podcast called Altered States of Context about the intersection of psychedelics and psychotherapy and is affiliate faculty at the Oregon Health and Science University.
Jeff Goldenberg

Abacus Agency

Co-founder

Jeff Goldenberg is the Co-Founder of Ministry of Sativa. He also co-founded Dodi Blunts, along with NFL Superstar Marshawn Lynch, a brand of diamond infused blunts sold in California. He is also the Co-Founder and Chief Strategy Officer of Abacus Growth Agency, voted the best cannabis advertising agency. He was formerly a co-founder of High 12 Brands (now Materia Ventures), a cannabis CPG brand factory.
Hardeep Shoker

Elevated Signals

Chief Product Officer

Hardeep is Chief Product Officer and one of the co-founders of Elevated Signals, an organization that develops GMP-validated manufacturing software for the cannabis industry. With a strong focus on quality, the company manages 8+ million sq ft of production area represented by craft producers right through to enterprise level operators.

Day-to-day Hardeep helps Licensed Producers get the most out of their teams by leveraging technology to streamline operations, and compliance. Having a technical and management background, he helps his peers navigate tough choices around change management and make data-led decisions. With over 14 years of experience in software development, he is passionate about bringing technical best practices from other industries and applying them to the cannabis space, in order to help the market become sustainable from both an operating and business perspective.

Prior to co-founding Elevated Signals, Hardeep was a Lead Software Developer at Adobe. He studied Computing Science at Simon Fraser University in British Columbia.
Chris Budd

Isolocity

Director of Sales

Chris began his QA career working for Magna International in corporate quality systems. After Magna, he earned an MBA at the Rotman School of Management, University of Toronto, while simultaneously launching his consultingpractice, CJB Consulting Ltd. CJB began consulting in the design and deployment of ISO & GMP QMS systems in awide variety of businesses. The Isolocity software was launched in 2016 with the intent to eliminate all paper and labour with quality compliance. Today Isolocity is used by businesses on every continent. Chris is an IRCA Certified Quality Systems Auditor and is also a Six Sigma Black Belt.
Natalie Villeneuve



Natalie Villeneuve is a clinical therapist specializing in trauma and sexual abuse prevention through her work with adolescents who have sexually offended. Currently based out of Toronto, Canada, Natalie assesses and treats youth who have experienced physical, sexual, and emotional abuse, as well as youth who have engaged in sexually abusive behaviours. Natalie completed her Masters of Social Work (MSW) at McGill University, where her research focused on understanding treatment needs for Indigenous youth who have sexually offended. Natalie has delivered numerous presentations on working with youth who sexually offend, and she is interested in understanding how Indigenous wisdom can be blended with Western science to enhance current healing practices and offer more wholistic approaches to treating trauma. She is interested in the role that psychedelics can bring to trauma therapy, and her current work focuses on how the psychedelic movement can progress in a way that is safe, ethical, decolonized, and free from sexual abuse.
Christopher Tasker

Global Cannabinoid Solutions

Founder & CEO

Chris is a Master of cannabinoid research helping build the next generation of cannabis businesses. Author of “The Cannamanual”, Chris and his organization help cannabis entrepreneurs leverage the rare expertise of cannabis scientists on the frontiers of research to make the industry safer, smarter, and more scientific.
Tamara Lilien

CannSell

Head of Education

After working for over a decade in academic healthcare and being inspired by the first-hand benefits of medical cannabis, Tamara took a leap out of the corporate world in 2018 to start her own company, CannaLily Consulting. Since then, she has successfully completed a level 2 Cannabis Sommelier certification (CannaReps), an Interpener certification (Trichome Institute) and a Cannabis Educator certification (Michener Institute). In 2019, she was selected from 25000 applicants to serve as one of five members of the world’s only Cannabis Curation Committee. Her newest endeavour finds her taking on the role of Head of Education at CannSell.

Tamara is passionate about educating the masses, dispelling cannabis myths and creating accessible communities.

IG & FB: @cannalily.consulting LinkedIn: https://www.linkedin.com/in/tamara-lilien/

Website: https://www.cannalily.ca/
Carl K Linn

Founder, Thai Hub of Cannabis

Author, Cannabis in Thailand

Carl is a cannabis policy analyst and advocate from Washington DC currently living in Phuket Thailand where he writes the Substack newsletter, Cannabis in Thailand. His company Thai Hub of Cannabis distributes cannabis grown in Thailand’s Northeast region to dispensaries and cafes on the island of Phuket. He reports on cannabis legal reform in Thailand as well as import & export policy in ongoing efforts to assess what makes growth happen in the new Thai cannabis sector.
Samantha Tabone


Chemist and Pharmaceutical Scientist

Trained as a chemist and pharmaceutical scientist, Samantha has eight years of experience working with early stage therapeutics development and biotechnology companies entering growth stages and clinical development life cycles. Her areas of expertise are central nervous system disorders, neuroscience biotechnology, and psychoactive therapeutics. Samantha’s skillset is strong on both the operational side with a demonstrated history of assisting startups with the maturation of their corporate development and enterprise portfolio management strategies in addition to the investor side, performing due diligence activities for both venture capital firms and investment banks with active holdings in the life sciences. Samantha has had a large client base seeking to develop research and development initiatives in both the cannabis and psychedelics arenas and is in tune with the psychedelics movement from both an industrial and academic perspective.
Mark Johnson

Centricity Research

Chief Executive Officer and Medical Director

Dr. Mark Johnston has been practicing psychiatry for over 15 years. His focus has always been on our aging community and what can be done to improve quality of life. He is dedicated to contributing to the effort to find a cure for Alzheimer’s disease through conducting numerous clinical trials at his research clinics in Kentville and Halifax.

Cannabis

360

Thanks for your subscription.
We will notify you soon...

Cannabis

360

Welcome to Cannabis360​

Are you 19 years of age?​

No, I'm under 19
Yes, Please Enter